For most of the twentieth century, neuroscience textbooks stated a simple rule: the adult brain does not grow new neurons. That claim is now definitively wrong. A 2025 to 2026 wave of research has confirmed that adult neurogenesis persists in the human hippocampus and identified the unlikely cells orchestrating the process: microglia, the brain’s resident immune cells, long dismissed as biological janitors. A 2026 study published in the NIH database demonstrated that modulating microglial activity selectively restored emotional behavior in animal models, independent of neurotransmitter manipulation [NIH PubMed]. The finding matters because it reframes how clinicians think about depression, anxiety, and cognitive decline. If microglia determine which newborn neurons live or die, mental wellness may depend less on serotonin levels and more on the inflammatory state of cells most people have never heard of.
The Brain Never Stops Growing
The belief persists: once you reach adulthood, the neurons you have are all you will ever get.
Photo by This misconception held scientific authority for over a century, and traces of it still appear in popular psychology. The corrected picture is far more dynamic.
The hippocampus, a seahorse-shaped structure critical for memory and mood, continuously generates new neurons throughout life, a process called neurogenesis. Carbon-14 dating studies of human brain tissue confirmed that hundreds of new hippocampal neurons appear daily in healthy adults. Yet producing neurons is only half the equation. Fewer than half of these newborn cells survive long enough to integrate into existing circuits.
Lifestyle factors influence the birth rate significantly:
-
Aerobic exercise has been shown to double hippocampal neurogenesis rates in animal models
-
Chronic stress suppresses new neuron production through cortisol-mediated pathways
-
Sleep deprivation disrupts the microenvironment newborn neurons need to mature
Even under optimal conditions, survival is not guaranteed. Something else selects which neurons make the cut, and for decades neuroscience overlooked the answer hiding in plain sight.
What Microglia Actually Do
Most people assume the brain’s immune system works like the body’s: white blood cells rushing in to fight infection.
Photo by Inside the skull, the reality is different. Microglia comprise roughly 10 to 15% of all brain cells and are permanent residents, not visiting responders. They never leave.
Live imaging reveals microglial processes extending and retracting every few minutes, scanning local territory with remarkable speed. Their surveillance role has been recognized for years, but their influence on living, developing neurons was long overlooked. The old textbook model cast them as phagocytes, cells that passively consumed dead material without shaping what survived.
That model was incomplete. Microglia release signaling molecules called cytokines that can either nurture or destroy fragile newborn neurons depending on context:
-
Anti-inflammatory cytokines such as IL-4 and IL-10 promote neuronal survival and dendritic growth
-
Pro-inflammatory cytokines such as TNF-alpha accelerate programmed cell death in immature neurons
Microglia also perform synaptic pruning, eliminating weak connections so stronger ones can consolidate. Complement proteins tag underused synapses, and microglia engulf them. This is architectural refinement, not destruction for its own sake. The distinction between passive cleanup and active construction turns out to be the key misconception that delayed the field for decades.
Busting the Passive Bystander Myth
The belief that microglia merely tidied up after neuronal death persisted in mainstream neuroscience well into the 2000s.
Photo by Researchers who suggested otherwise faced skepticism. Advances in live-cell imaging and genetic manipulation tools finally forced a reckoning.
The most compelling evidence came from depletion experiments. When researchers used CSF1R inhibitors to eliminate microglia from adult mouse brains, hippocampal neurogenesis collapsed, dropping by more than 50% within weeks. If microglia were merely janitors, removing them should have had no effect on neuron production. Instead, the system fell apart.
Sierra and colleagues added another layer by demonstrating that microglia actively engulf newborn neurons that fail developmental quality checkpoints. This phagocytosis happens within hours of a cell beginning to die, preventing inflammatory debris from damaging healthy neighbors. Far from passive bystanders, microglia function as quality-control inspectors on a biological assembly line, clearing defective cells before they compromise the whole operation.
The corrected understanding repositions microglia as instructive regulators, not reactive scavengers. They do not wait for neurons to fail; they actively participate in determining which ones succeed.
How Microglia Shape New Neurons
The mechanisms are more sophisticated than a simple live-or-die verdict.
Photo by Microglia regulate neurogenesis through at least three distinct channels operating simultaneously.
Direct physical contact comes first. Microglia extend processes that touch newborn neurons and release brain-derived neurotrophic factor (BDNF), a growth molecule critical for dendritic development and synaptic integration. Without microglial-derived BDNF, adult-born hippocampal neurons struggle to wire into existing memory circuits.
Chemical environment management is the second channel. When microglia shift into a chronically inflammatory state, triggered by sustained stress, infection, or aging, they flood the local environment with pro-inflammatory signals. Chronic neuroinflammation can reduce hippocampal neurogenesis by up to 75% in animal models, with similar patterns observed in human postmortem tissue. Newborn neurons, lacking the protective myelin sheaths of mature cells, are especially vulnerable.
The third channel is protective clearance. When a newborn neuron begins apoptosis, efficient microglial phagocytosis prevents secondary necrosis, a messier form of cell death that releases inflammatory molecules harmful to neighboring healthy neurons. Rapid cleanup protects the broader neurogenic niche.
This triple-layered regulation means the inflammatory state of microglia, not just the raw number of new neurons produced, determines the functional outcome of neurogenesis.
Links to Mental Health Conditions
The connection between microglial dysfunction and psychiatric illness is no longer speculative.
Photo by Postmortem brain studies of individuals with major depressive disorder reveal elevated microglial activation markers alongside significantly reduced newborn neuron counts in the hippocampus. The pattern is consistent: inflamed microglia, fewer surviving neurons, smaller hippocampal volume.
A 2026 study found that microglial modulation selectively restored affective behavior in animal models without the cognitive trade-offs seen when newborn neuron activity was simply suppressed [NIH PubMed]. Suppressing neuronal activity broadly impaired cognition, but targeting the microglial inflammatory state preserved cognitive function while alleviating emotional pathology. That distinction carries real clinical weight.
SSRIs and other antidepressants appear to work partly through this pathway. Fluoxetine treatment in rodents restored neurogenesis rates and normalized microglial morphology within four weeks, a timeline that mirrors the delayed therapeutic response patients typically experience. The weeks-long wait for antidepressants to take effect may reflect the time microglia need to shift from an inflammatory to a neuroprotective state.
Chronic stress compounds the problem through a self-reinforcing cycle: cortisol activates microglia via glucocorticoid receptors, triggering inflammatory cascades that suppress neuron birth, which worsens mood, which elevates cortisol further. Breaking this loop may require targeting microglial inflammation directly, not just adjusting serotonin.
Practical Implications for Brain Health
This research reframes familiar wellness advice.
Photo by Exercise, sleep, and stress reduction are not vague lifestyle recommendations. They directly influence the cellular machinery governing brain renewal.
-
Omega-3 fatty acids shift microglia toward neuroprotective states in both animal and preliminary human studies
-
Regular aerobic exercise reduces microglial inflammatory markers and promotes BDNF release
-
Adequate sleep allows microglia to perform maintenance functions, including debris clearance, that are suppressed during wakefulness
-
Mindfulness-based stress reduction lowered inflammatory cytokine levels measurably within eight weeks in clinical trials
On the pharmaceutical frontier, researchers are exploring anti-inflammatory compounds that target microglial states specifically. Early-phase trials of minocycline, an antibiotic with anti-inflammatory microglial effects, showed promising antidepressant results in treatment-resistant patients. The approach represents a notable conceptual shift: treating depression not as a neurotransmitter deficit but as a neuroinflammatory condition.
None of this means abandoning existing treatments. The most effective strategies may eventually combine neurotransmitter-based therapies with interventions that restore healthy microglial function, addressing both the chemistry and the cellular architecture of mood regulation.
Microglia have moved from the margins of neuroscience to its center, now recognized as active architects of adult neurogenesis rather than passive bystanders. They determine which new hippocampal neurons survive, shape emotional resilience, and influence vulnerability to depression and anxiety. For anyone interested in supporting cognitive and emotional well-being, the evidence points toward a consistent theme: reducing chronic inflammation through movement, rest, nutrition, and stress management protects the very cells that protect your brain’s capacity to renew itself.
